Autologous CAR-T Cells Targeting B7-H3 in PDAC

NCT06158139 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Relapse
Resistant Cancer

Interventions

BIOLOGICAL: iC9-CAR.B7-H3 T cell infusion

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]